Year archive

NeoImmuneTech, Inc. — 2025 filings

All 51 regulatory filings released by NeoImmuneTech, Inc. (950220) in 2025, sourced directly from the official regulator.

51 Filings

2025 Period

2025 filings (51)

Filing	Released	Lang
전환청구권행사 (제1회차) Capital/Financing Update	2025-12-24	Korean
투자판단관련주요경영사항 (겸상적혈구질환 치료제 북미 지역 제반 권리(판매권, 유통권, 상표권 등)에 대한 라이선스 도입의 건) M&A Activity	2025-12-17	Korean
기타경영사항(자율공시) (제12기 정기주주총회 권리주주 확정을 위한 증권예탁증권 기준일 설정 공고) AGM Information	2025-12-16	Korean
분기보고서 (2025.09) Regulatory Filings	2025-11-07	Korean
주식등의대량보유상황보고서(일반) Regulatory Filings	2025-10-16	Korean
대표이사변경 Regulatory Filings	2025-10-10	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2025-09-18	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2025-09-18	Korean
증권발행결과(자율공시) (주주배정 후 실권주 일반공모) Share Issue/Capital Change	2025-09-16	Korean
증권발행실적보고서 Share Issue/Capital Change	2025-09-16	Korean
유상증자또는주식관련사채등의청약결과(자율공시) (주주배정후 실권주 일반공모) Share Issue/Capital Change	2025-09-15	Korean
유상증자또는주식관련사채등의청약결과(자율공시) (주주배정후 실권주 일반공모) Share Issue/Capital Change	2025-09-10	Korean
유상증자최종발행가액확정 (주주배정후 실권주 일반공모) Capital/Financing Update	2025-09-04	Korean
[기재정정]주요사항보고서(유상증자결정) Share Issue/Capital Change	2025-09-04	Korean
[발행조건확정]증권신고서(증권예탁증권) Capital/Financing Update	2025-09-04	Korean
[기재정정]투자설명서 Capital/Financing Update	2025-09-04	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2025-08-21	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2025-08-21	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2025-08-21	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Major Shareholding Notification	2025-08-20	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2025-08-20	Korean
[기재정정]증권신고서(증권예탁증권) Capital/Financing Update	2025-08-20	Korean
투자판단관련주요경영사항(임상시험결과) (NIT112 (거대 B세포 림프종, NTI7 및 CART 치료제 병용 요법) 임상 1b상 임상시험결과보고서(CSR) 수령) Legal Proceedings Report	2025-08-19	Korean
반기보고서 (2025.06) Interim / Quarterly Report H1 2025	2025-08-14	Korean
유상증자1차발행가액결정 Capital/Financing Update	2025-07-30	Korean
[발행조건확정]증권신고서(증권예탁증권) Capital/Financing Update	2025-07-30	Korean
[기재정정]투자설명서 Capital/Financing Update	2025-07-30	Korean
[기재정정]주요사항보고서(유상증자결정) Share Issue/Capital Change	2025-07-30	Korean
권리락 (유상증자) Share Issue/Capital Change	2025-07-30	Korean
[기재정정]주요사항보고서(유상증자결정) Share Issue/Capital Change	2025-07-30	Korean
기업설명회(IR)개최 Report Publication Announcement	2025-07-21	Korean
임원ㆍ주요주주특정증권등거래계획보고서 Major Shareholding Notification	2025-07-18	Korean
투자설명서 Investor Presentation	2025-07-07	Korean
[기재정정]증권신고서(증권예탁증권) Investor Presentation	2025-07-04	Korean
[기재정정]증권신고서(증권예탁증권) Capital/Financing Update	2025-06-20	Korean
주요사항보고서(유상증자결정) Share Issue/Capital Change	2025-05-30	Korean
증권신고서(증권예탁증권) Capital/Financing Update	2025-05-30	Korean
기업설명회(IR)개최 Report Publication Announcement	2025-05-20	Korean
투자판단관련주요경영사항(임상시험결과) (NIT112 (거대 B세포 림프종, NTI7 및 CART 치료제 병용 요법) 임상 1b상 Topline Data 발표) Regulatory Filings	2025-05-19	Korean
분기보고서 (2025.03) Interim / Quarterly Report Q1 2025	2025-05-15	Korean
전환가액의조정 (제1회차) Share Issue/Capital Change	2025-04-30	Korean
기업설명회(IR)개최 Report Publication Announcement	2025-04-03	Korean
정기주주총회결과 Declaration of Voting Results & Voting Rights Announcements	2025-03-31	Korean
기업설명회(IR)개최 Report Publication Announcement	2025-03-26	Korean
사업보고서 (2024.12) Annual Report FY 2024	2025-03-21	Korean
감사보고서제출 Audit Report / Information FY 2024	2025-03-20	Korean
주주총회소집결의 AGM Information	2025-03-14	Korean
주주총회소집공고 AGM Information	2025-03-14	Korean
의결권대리행사권유참고서류 Proxy Solicitation & Information Statement	2025-03-14	Korean
매출액또는손익구조30%(대규모법인은15%)미만변동(자율공시) Earnings Release FY 2024	2025-02-14	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2025-01-10	Korean